{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:15:00Z","timestamp":1768407300533,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T00:00:00Z","timestamp":1438646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T00:00:00Z","timestamp":1438646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/gt.2015.84","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T14:41:32Z","timestamp":1438699292000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams"],"prefix":"10.1038","volume":"23","author":[{"given":"M","family":"Kano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Rahmutulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Hiwasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,4]]},"reference":[{"key":"BFgt201584_CR1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893\u20132917.","journal-title":"Int J Cancer"},{"key":"BFgt201584_CR2","doi-asserted-by":"publisher","first-page":"170325","DOI":"10.1155\/2012\/170325","volume":"2012","author":"R Mirzayans","year":"2012","unstructured":"Mirzayans R, Andrais B, Scott A, Murray D . New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy. J Biomed Biotechnol 2012; 2012: 170325.","journal-title":"J Biomed Biotechnol"},{"key":"BFgt201584_CR3","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1158\/1078-0432.CCR-11-0046","volume":"17","author":"D Sano","year":"2011","unstructured":"Sano D, Xie TX, Ow TJ, Zhao M, Pickering CR, Zhou G et al. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clin Cancer Res 2011; 17: 6658\u20136670.","journal-title":"Clin Cancer Res"},{"key":"BFgt201584_CR4","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/sj.onc.1205176","volume":"21","author":"H Shimada","year":"2002","unstructured":"Shimada H, Liu TL, Ochiai T, Shimizu T, Haupt Y, Hamada H et al. Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33ING1 in T.Tn human esophageal carcinoma cells. Oncogene 2002; 21: 1208\u20131216.","journal-title":"Oncogene"},{"key":"BFgt201584_CR5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1349-7006.2006.00206.x","volume":"97","author":"H Shimada","year":"2006","unstructured":"Shimada H, Matsubara H, Shiratori T, Shimizu T, Miyazaki S, Okazumi S et al. Phase I\/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma. Cancer Sci 2006; 97: 554\u2013561.","journal-title":"Cancer Sci"},{"key":"BFgt201584_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1349-7006.2009.01381.x","volume":"101","author":"H Kawahira","year":"2010","unstructured":"Kawahira H, Matsushita K, Shimada H, Shimizu T, Nabeya Y, Hayashi H et al. Viral shedding after p53 adenoviral gene therapy in 10 cases of esophageal cancer. Cancer Sci 2010; 101: 289\u2013291.","journal-title":"Cancer Sci"},{"key":"BFgt201584_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(01)00223-9","volume":"104","author":"J Liu","year":"2001","unstructured":"Liu J, Akoulitchev S, Weber A, Ge H, Chuikov S, Libutti D et al. Defective interplay of activators and repressors with TFIH in xeroderma pigmentosum. Cell 2001; 104: 353\u2013363.","journal-title":"Cell"},{"key":"BFgt201584_CR8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1158\/0008-5472.CAN-04-4459","volume":"66","author":"K Matsushita","year":"2006","unstructured":"Matsushita K, Tomonaga T, Shimada H, Shioya A, Higashi M, Matsubara H et al. An essential role of alternative splicing of c-myc suppressor FIR in carcinogenesis. Cancer Res 2006; 66: 1409\u20131417.","journal-title":"Cancer Res"},{"key":"BFgt201584_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cas.12058","volume":"104","author":"T Kajiwara","year":"2013","unstructured":"Kajiwara T, Matsushita K, Itoga S, Tamura M, Tanaka N, Tomonaga T et al. SAP155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues. Cancer Sci 2013; 104: 149\u2013156.","journal-title":"Cancer Sci"},{"key":"BFgt201584_CR10","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.18632\/oncotarget.3244","volume":"6","author":"K Matsushita","year":"2014","unstructured":"Matsushita K, Kitamura K, Rahmutulla B, Tanaka N, Ishige T, Satoh M et al. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1. Oncotarget 2014; 6: 5102\u20135117.","journal-title":"Oncotarget"},{"key":"BFgt201584_CR11","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.18632\/oncotarget.1650","volume":"5","author":"B Rahmutulla","year":"2014","unstructured":"Rahmutulla B, Matsushita K, Satoh M, Seimiya M, Tsuchida S, Kubo S et al. Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1\/cyclinE and Ku86\/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway. Oncotarget 2014; 5: 2404\u20132417.","journal-title":"Oncotarget"},{"key":"BFgt201584_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1158\/1541-7786.MCR-12-0673","volume":"11","author":"K Matsushita","year":"2013","unstructured":"Matsushita K, Tamura M, Tanaka N, Tomonaga T, Matsubara H, Shimada H et al. Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-myc and P27Kip1 expression. Mol Can Res 2013; 11: 689\u2013698.","journal-title":"Mol Can Res"},{"key":"BFgt201584_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1158\/1541-7786.MCR-11-0462","volume":"10","author":"K Matsushita","year":"2012","unstructured":"Matsushita K, Kajiwara T, Tamura M, Satoh M, Tanaka N, Tomonaga T et al. SAP155-mediated splicing of FUSE-binding protein-interacting repressor (FIR) serves as a molecular switch for c-myc gene expression. Mol Cancer Res 2012; 10: 787\u2013799.","journal-title":"Mol Cancer Res"},{"key":"BFgt201584_CR14","doi-asserted-by":"publisher","first-page":"17305","DOI":"10.3748\/wjg.v20.i46.17305","volume":"20","author":"B Rahmutulla","year":"2014","unstructured":"Rahmutulla B, Matsushita K, Nomura F . Alternative splicing of DNA damage response genes and gastrointestinal cancers. World J Gastroenterol 2014; 20: 17305\u201317313.","journal-title":"World J Gastroenterol"},{"key":"BFgt201584_CR15","doi-asserted-by":"crossref","unstructured":"Tanaka N, Araki K, Mizokami D, Miyagawa Y, Yamashita T, Tomifuji M et al. Sendai virus-mediated c-myc suppressor far-upstream element binding protein interacting repressor gene transfer suppresses head and neck squamous cell carcinoma. Gene Therapy 2015.","DOI":"10.1038\/gt.2014.123"},{"key":"BFgt201584_CR16","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/j.1349-7006.2011.01931.x","volume":"7","author":"A Kitamura","year":"2011","unstructured":"Kitamura A, Matsushita K, Takiguchi Y, Shimada H, Tada Y, Yamanaka M et al. Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in treatment of malignant pleural mesothelioma. Cancer Sci 2011; 7: 1366\u20131373.","journal-title":"Cancer Sci"},{"key":"BFgt201584_CR17","doi-asserted-by":"publisher","first-page":"e0116279","DOI":"10.1371\/journal.pone.0116279","volume":"10","author":"D Mizokami","year":"2015","unstructured":"Mizokami D, Araki K, Tanaka N, Suzuki H, Tomifuji M, Yamashita T et al. Gene therapy of c-myc suppressor FUSE-binding protein-interacting repressor by Sendai virus delivery prevents tracheal stenosis. Plos One 2015; 10: e0116279.","journal-title":"Plos One"},{"key":"BFgt201584_CR18","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.2741\/3461","volume":"1","author":"K Matsushita","year":"2009","unstructured":"Matsushita K, Tomonaga T, Kajiwara T, Shimada H, Itoga S, Hiwasa T, Kubo S, Ochiai T, Matsubara H, Nomura F . c-myc suppressor FBP-interacting repressor for cancer diagnosis and therapy. Front Biosci 2009; 1: 3401\u20133408.","journal-title":"Front Biosci"},{"key":"BFgt201584_CR19","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/jso.22127","volume":"105","author":"Y Akutsu","year":"2012","unstructured":"Akutsu Y, Yasuda S, Nagata M, Izumi Y, Okazumi S, Shimada H et al. A phase I\/II clinical trial of preoperative short-course carbon-ion radiotherapy for patients with squamous cell carcinoma of the esophagus. J Surg Oncol 2012; 105: 750\u2013755.","journal-title":"J Surg Oncol"},{"key":"BFgt201584_CR20","first-page":"4433","volume":"29","author":"M Kano","year":"2009","unstructured":"Kano M, Yamada S, Hoshino I, Murakami K, Akutsu Y, Sakata H et al. Effects of carbon-ion radiotherapy combined with a novel histone deacetylase inhibitor, cyclic hydroxamic-acid-containing peptide 31 in human esophageal squamous cell carcinoma. Anticancer Res 2009; 29: 4433\u20134438.","journal-title":"Anticancer Res"},{"issue":"suppl 2","key":"BFgt201584_CR21","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/S0167-8140(04)80012-4","volume":"73","author":"H Tsujii","year":"2004","unstructured":"Tsujii H, Mizoe JE, Kamada T, Baba M, Kato S, Kato H et al. Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol 2004; 73 (suppl 2): S41\u2013S49.","journal-title":"Radiother Oncol"},{"key":"BFgt201584_CR22","doi-asserted-by":"publisher","first-page":"e115121","DOI":"10.1371\/journal.pone.0115121","volume":"9","author":"N Amornwichet","year":"2014","unstructured":"Amornwichet N, Oike T, Shibata A, Ogiwara H, Tsuchiya N, Yamauchi M et al. Carbon-ion beam irradiation kills X-ray-resistant TP53-null cancer cells by inducing mitotic catastrophe. PLoS One 2014; 9: e115121.","journal-title":"PLoS One"},{"key":"BFgt201584_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrclinonc.2013.79","volume":"10","author":"JS Loeffler","year":"2013","unstructured":"Loeffler JS, Durante M . Charged particle therapy\u2014optimization, challenges and future directions. Nat Rev Clin Oncol 2013; 10: 411\u2013424.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFgt201584_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-4-431-54457-9_24","volume-title":"Postoperative Recurrence of Rectal Cancer. Carbon-Ion Radiotherapy: Principles, Practices, and Treatment Planning","author":"S Yamada","year":"2014","unstructured":"Yamada S . Postoperative Recurrence of Rectal Cancer. Carbon-Ion Radiotherapy: Principles, Practices, and Treatment Planning. Springer: Tokyo, 2014: 203\u2013209."},{"key":"BFgt201584_CR25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00595-006-3231-8","volume":"36","author":"K Matsushita","year":"2006","unstructured":"Matsushita K, Ochiai T, Shimada H, Kato S, Ohno T, Nikaido T et al. The effects of carbon ion irradiation revealed by excised perforated intestines as a late morbidity for uterine cancer treatment. Surg Today 2006; 36: 692\u2013700.","journal-title":"Surg Today"},{"key":"BFgt201584_CR26","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.3748\/wjg.v20.i15.4316","volume":"20","author":"K Matsushita","year":"2014","unstructured":"Matsushita K, Shimada H, Ueda Y, Inoue M, Hasegawa M, Tomonaga T et al. Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy. World J Gastroenterol 2014; 20: 4316\u20134328.","journal-title":"World J Gastroenterol"},{"key":"BFgt201584_CR27","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/onc.2009.492","volume":"29","author":"F Dong","year":"2010","unstructured":"Dong F, Soubeyrand S, Hach\u00e9 RJ . Activation of PARP-1 in response to bleomycin depends on the Ku antigen and protein phosphatase 5. Oncogene 2010; 29: 2093\u20132103.","journal-title":"Oncogene"},{"key":"BFgt201584_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0027-5107(96)00023-1","volume":"355","author":"LF Povirk","year":"1996","unstructured":"Povirk LF . DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enediynes. Mutat Res 1996; 355: 71\u201389.","journal-title":"Mutat Res"},{"key":"BFgt201584_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1749-6632.1999.tb07928.x","volume":"887","author":"L Ben\u00edtez-Bribiesca","year":"1999","unstructured":"Ben\u00edtez-Bribiesca L, S\u00e1nchez-Su\u00e1rez P . Oxidative damage, bleomycin, and gamma radiation induce different types of DNA strand breaks in normal lymphocytes and thymocytes. A comet assay study. Ann NY Acad Sci 1999; 887: 133\u2013149.","journal-title":"Ann NY Acad Sci"},{"key":"BFgt201584_CR30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/35077232","volume":"411","author":"JH Hoeijmakers","year":"2001","unstructured":"Hoeijmakers JH . Genome maintenance mechanisms for preventing cancer. Nature 2001; 411: 366\u2013374.","journal-title":"Nature"},{"key":"BFgt201584_CR31","first-page":"563","volume":"25","author":"G Oohira","year":"2004","unstructured":"Oohira G, Yamada S, Ochiai T, Matsubara H, Okazumi S, Ando K et al. Growth suppression of esophageal squamous cell carcinoma induced by heavy carbon-ion beams combined with p53 gene transfer. Int J Oncol 2004; 25: 563\u2013569.","journal-title":"Int J Oncol"},{"key":"BFgt201584_CR32","first-page":"11","volume":"9","author":"M Imamura","year":"2002","unstructured":"Imamura M, Sawada S, Kasahara-Imamura M, Harima K, Harada K . Synergistic cell-killing effect of a combination of hyperthermia and heavy ion beam irradiation: in expectation of a breakthrough in the treatment of refractory cancers (review). Int J Mol Med 2002; 9: 11\u201318.","journal-title":"Int J Mol Med"},{"key":"BFgt201584_CR33","first-page":"2037","volume":"22","author":"I Asakawa","year":"2002","unstructured":"Asakawa I, Yoshimura H, Takahashi A, Ohnishi K, Nakagawa H, Ota I et al. Radiation-induced growth inhibition in transplanted human tongue carcinomas with different P53 gene status. Anticancer Res 2002; 22: 2037\u20132043.","journal-title":"Anticancer Res"},{"key":"BFgt201584_CR34","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0360-3016(01)01514-0","volume":"50","author":"Y Iwadate","year":"2001","unstructured":"Iwadate Y, Mizoe J, Osaka Y, Ohnishi K, Nakagawa H, Ota I et al. High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53. Int J Radiat Oncol Biol Phys 2001; 50: 803\u2013808.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFgt201584_CR35","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1200\/JCO.2002.10.050","volume":"20","author":"T Kamada","year":"2002","unstructured":"Kamada T, Tsujii H, Tsuji H, Yanagi T, Mizoe JE, Miyamoto T et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. Working Group for the Bone and Soft Tissue Sarcomas. J Clin Oncol 2002; 20: 4466\u20134471.","journal-title":"J Clin Oncol"},{"key":"BFgt201584_CR36","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1378\/chest.122.6.1925","volume":"122","author":"K Kadono","year":"2002","unstructured":"Kadono K, Homma T, Kamahara K, Nakayama M, Satoh H, Sekizawa K et al. Effect of heavy-ion radiotherapy on pulmonary function in stage I non-small cell lung cancer patients. Chest 2002; 122: 1925\u20131932.","journal-title":"Chest"},{"key":"BFgt201584_CR37","first-page":"362","volume":"5","author":"T Nakano","year":"1999","unstructured":"Nakano T, Suzuki M, Abe A, Suzuki Y, Morita S, Mizoe J et al. The phase I\/II clinical study of carbon ion therapy for cancer of the uterine cervix. Cancer J Sci Am 1999; 5: 362\u2013369.","journal-title":"Cancer J Sci Am"},{"key":"BFgt201584_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1269\/jrr.09111","volume":"51","author":"A Takahashi","year":"2010","unstructured":"Takahashi A, Mori E, Ohnishi T . The foci of DNA double strand break-recognition proteins localize with \u03b3H2AX after heat treatment. J Radiat Res (Tokyo) 2010; 51: 91\u201395.","journal-title":"J Radiat Res (Tokyo)"},{"key":"BFgt201584_CR39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5794\/jjoms.36.307","volume":"36","author":"K Takahashi","year":"1990","unstructured":"Takahashi K, Kanazawa H, Chan H . A case of esophageal carcinoma metastatic to the mandible and characterization of two cell lines (T.T. and T.Tn). Jpn. J Oral Maxillofac Surg 1990; 36: 307\u2013316.","journal-title":"Jpn. J Oral Maxillofac Surg"},{"key":"BFgt201584_CR40","first-page":"575","volume":"70","author":"T Nishihira","year":"1979","unstructured":"Nishihira T, Kasai M, Mori S et al. Characteristics of two cell lines (TE-1 and TE-2) derived from human squamous cell carcinoma of the esophagus. Gann 1979; 70: 575\u2013584.","journal-title":"Gann"},{"key":"BFgt201584_CR41","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1158\/1078-0432.CCR-10-1996","volume":"17","author":"H Saeki","year":"2011","unstructured":"Saeki H, Kitao H, Yoshinaga K, Nakanoko T, Kubo N, Kakeji Y et al. Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations. Clin Cancer Res 2011; 17: 1731\u20131740.","journal-title":"Clin Cancer Res"},{"key":"BFgt201584_CR42","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/carcin\/14.5.987","volume":"14","author":"IC Hsu","year":"1993","unstructured":"Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T et al. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 1993; 14: 987\u2013992.","journal-title":"Carcinogenesis"},{"key":"BFgt201584_CR43","doi-asserted-by":"publisher","first-page":"21439","DOI":"10.1074\/jbc.271.35.21439","volume":"271","author":"K Kimura","year":"1996","unstructured":"Kimura K, Nozaki N, Enomoto T, Tanaka M, Kikuchi A . Analysis of M phase-specific phosphorylation of DNA topoisomerase II. J Biol Chem 1996; 271: 21439\u201321445.","journal-title":"J Biol Chem"},{"key":"BFgt201584_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0014-5793(03)00918-9","volume":"552","author":"T Hiwasa","year":"2003","unstructured":"Hiwasa T, Shimada H, Sakaida T, Kitagawa M, Kuroiwa N, Ochiai T et al. Drug-sensitivity pattern analysis of study of functional relationship between gene products. FEBS Lett 2003; 552: 177\u2013183.","journal-title":"FEBS Lett"},{"key":"BFgt201584_CR45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1667\/RR13782.1","volume":"182","author":"A Takahashi","year":"2014","unstructured":"Takahashi A, Kubo M, Ma H, Nakagawa A, Yoshida Y, Isono M et al. Non-homologous end-joining repair plays a more important role than homologous recombination repair in defining radiosensitivity after exposure to high-LET radiation. Radiat Res 2014; 182: 338\u2013344.","journal-title":"Radiat Res"},{"key":"BFgt201584_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0360-3016(98)00544-6","volume":"44","author":"T Kanai","year":"1999","unstructured":"Kanai T, Endo M, Minohara S, Miyahara N, Koyama-ito H, Tomura H et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys 1999; 44: 201\u2013210.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFgt201584_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/095530098141799","volume":"74","author":"K Ando","year":"1998","unstructured":"Ando K, Koike S, Nojima K, Chen YJ, Ohira C, Ando S et al. Mouse skin reactions following fractionated irradiation with carbon ions. Int J Radiat Biol 1998; 74: 129\u2013138.","journal-title":"Int J Radiat Biol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201584.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201584","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201584.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:08:13Z","timestamp":1648559293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,4]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["BFgt201584"],"URL":"https:\/\/doi.org\/10.1038\/gt.2015.84","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,4]]},"assertion":[{"value":"25 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}